Soru

Zorluk: OrtaPharmacologic Interventions

A 6161-year-old woman presents to the emergency department with a 11-day history of sharp right-sided chest pain that worsens with deep inspiration, accompanied by progressive shortness of breath. She has a history of type 2 diabetes mellitus, hypertension, and stage 4 chronic kidney disease. Her current medications include amlodipine, insulin glargine, and atorvastatin. Temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 138/82 mmHg138/82\text{ mmHg}, pulse is 114/min114/\text{min}, and respirations are 22/min22/\text{min}. Pulse oximetry shows 92%92\% on room air. BMI is 34 kg/m234\text{ kg/m}^2. Physical examination is notable for mild swelling and tenderness in the right calf. Laboratory testing shows a serum creatinine of 2.9 mg/dL2.9\text{ mg/dL} (baseline 2.7 mg/dL2.7\text{ mg/dL}) and an estimated creatinine clearance of 17 mL/min17\text{ mL/min}. Computed tomography pulmonary angiography demonstrates a filling defect in the right lower lobe pulmonary artery. Transthoracic echocardiography reveals normal right ventricular size and function. Which of the following is the most appropriate initial pharmacologic intervention?

  1. Intravenous unfractionated heparinCevap
  2. B
    Subcutaneous enoxaparin
  3. C
    Oral rivaroxaban
  4. D
    Oral warfarin
  5. E
    Intravenous alteplase

Cevap

Intravenous unfractionated heparin
The correct answer is intravenous unfractionated heparin (UFH). This patient presents with an acute pulmonary embolism and is hemodynamically stable, mandating immediate systemic anticoagulation. However, her stage 4 chronic kidney disease (estimated creatinine clearance of 17 mL/min17\text{ mL/min}) strictly dictates the choice of agent. UFH is primarily metabolized and cleared by the reticuloendothelial system (macrophages) and endothelial cells, independent of renal function. Therefore, it is the anticoagulant of choice for patients with a creatinine clearance less than 30 mL/min30\text{ mL/min} who require acute therapeutic anticoagulation.

Adım Adım Çözüm

1
Diagnose the acute condition based on clinical presentation and imaging.
The patient has an acute pulmonary embolism (PE) confirmed by computed tomography pulmonary angiography, complicated by a likely deep vein thrombosis.
Chest pain, dyspnea, tachycardia, hypoxia, and right calf swelling are classic signs of VTE, which the imaging confirms.
2
Assess the patient's hemodynamic status and comorbidities to guide therapy.
The patient is hemodynamically stable (normal blood pressure, normal RV function) but has severe chronic kidney disease (creatinine clearance of 17 mL/min).
Stability rules out the need for systemic thrombolysis. The severe renal impairment narrows the choices of safe anticoagulants.
3
Select the optimal initial anticoagulant that avoids renal clearance.
Intravenous unfractionated heparin is chosen.
Unlike low-molecular-weight heparins and most direct oral anticoagulants, unfractionated heparin is cleared by the reticuloendothelial system and does not require dose adjustment or pose excessive bleeding risks in severe renal failure.

Anahtar Kavram

Pharmacologic management of venous thromboembolism in severe chronic kidney disease
Tahmini Süre:1m 30s
Bu soruyu puanla